M
Research Summary
AI-generated from SEC filings & financial news
Morgan Stanley
Morgan Stanley is a global financial services firm that underwrites and advises on capital markets, manages client assets, and provides brokerage and wealth-management services. It generates revenue from investment-banking fees, asset-management and advisory fees, brokerage commissions, net interest income, and trading and principal investing profits, leveraging a large client base and global distribution network.[1]
Business Segments
- Institutional Securities — capital markets, M&A advisory, underwriting, sales & trading (approx. ~40–45% of net revenues).[2]
- Wealth Management — client investing, financial advisory, brokerage and lending (approx. ~45–50% of net revenues).[2]
- Investment Management — asset management, investment products and performance fees (approx. ~8–12% of net revenues).[2]
Competitive Position
- Broad, diversified franchise across capital markets, wealth and asset management gives revenue stability and scale advantages versus pure-play competitors.[3]
- Large distribution network and extensive adviser base create scale in recurring fee businesses (asset management and wealth), producing sticky client relationships and cross-sell opportunities.[3]
Investment Considerations
- Opportunity: Wealth and investment-management scale can provide steady fee income and lower earnings volatility compared with capital-markets-only peers.[4]
- Risk: Significant exposure to market and underwriting cycles; trading and investment-banking revenues can be highly cyclical and sensitive to market volatility.[4]
- Risk: Regulatory, litigation and conduct exposures are material and can result in fines, capital impacts and reputational damage; strong compliance and capital management remain critical.[4]
- Opportunity/Risk: Funding and liquidity profile (including wholesale funding and deposit mix) is an important structural factor — well-managed liquidity supports markets businesses but dependence on market funding can increase vulnerability in stressed conditions.[4]
Market Data
$222.28+$15.62 (+7.56%)
MS · Last trade
Prev Close
$206.66
Range (29d)
$209.04 – $227.09
Recent Filings
- SCHEDULE 13G/A11.5 KBEaton Vance Ltd Duration Income FundJul 8, 6:55 PM ET·0000895421-26-000203
- SCHEDULE 13G/A12.3 KBMFS CHARTER INCOME TRUSTJul 8, 5:46 PM ET·0000895421-26-000202
- SCHEDULE 13G/A12.5 KBCervoMed Inc.Jul 8, 5:43 PM ET·0000895421-26-000201
- SCHEDULE 13G/A8.2 KBMFS INVESTMENT GRADE MUNICIPAL TRUSTJul 8, 5:36 PM ET·0000895421-26-000200
- SCHEDULE 13G8.3 KBZepp Health CorpJun 26, 5:01 PM ET·0000895421-26-000198
- 8-K325.4 KBMORGAN STANLEYJun 24, 4:52 PM ET·0000950103-26-009448
- SCHEDULE 13G/A8.1 KBTerns Pharmaceuticals, Inc.Jun 5, 4:21 PM ET·0000895421-26-000192
- SCHEDULE 13G/A13.7 KBINSIGHT ENTERPRISES INCJun 5, 4:16 PM ET·0000895421-26-000191
- SCHEDULE 13G/A12.5 KBApellis Pharmaceuticals, Inc.Jun 5, 4:14 PM ET·0000895421-26-000190
- SCHEDULE 13G/A13.7 KBBLACKBAUD INCJun 5, 4:12 PM ET·0000895421-26-000189
Insiders
10Tickers
Addresses
business
1585 BROADWAY
NEW YORK, NY, 10036
mailing
1585 BROADWAY
NEW YORK, NY, 10036
Former Names
- MORGAN STANLEY2026-07-08
- MORGAN STANLEY2026-07-08
- MORGAN STANLEY DEAN WITTER & CO2002-07-12
- MORGAN STANLEY DEAN WITTER DISCOVER & CO1998-03-18
- DEAN WITTER DISCOVER & CO1997-05-08